Sintilimab Plus NCT or NCRT Versus NCRT for ESCC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sintilimab Plus NCT or NCRT Versus NCRT for ESCC	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm	Not yet recruiting	Phase 3	2022-10-25		NCT05244798

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Anhui Provincial Hospital	101
Anyang Tumor Hospital	12
GeneCast Biotechnology Co., Ltd.	9
Hebei Medical University Fourth Hospital	83
Innovent Biologics (Suzhou) Co. Ltd.	82
Peking University Cancer Hospital & Institute	189
Shantou Central Hospital	13
Sichuan Cancer Hospital and Research Institute	64
The First Affiliated Hospital with Nanjing Medical University	319
Tianjin Medical University Cancer Institute and Hospital	287

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sichuan Cancer Hospital and Research Institute	Chengdu	China	7